The Carter Center announced that human Guinea worm cases reached a historic low of ten in 2025, moving the world closer to eradicating the parasite despite lingering infections in animals.
Guinea worm cases drop to historic low of ten global infections Read More »
Malawi has signed a five-year health cooperation agreement with the United States to strengthen its health system and support the fight against HIV, malaria and tuberculosis.
Malawi signs US deal to fight AIDS/HIV Read More »
WHO Director-General Tedros Adhanom Ghebreyesus has praised the strong leadership of African nations in various aspects of global health.
WHO chief praises Africa’s leadership in global health Read More »
The funding cuts, which affect the PEPFAR program, threaten to disrupt vital treatment and prevention efforts in a country with one of the highest HIV rates in the world.
US funding cuts threaten South Africa’s HIV fight Read More »
Gavi, the vaccine alliance, announced that nearly 10 million doses of the RTS,S malaria vaccine have been delivered to Africa since the rollout of routine immunization began.
Africa delivers 10 million malaria vaccine doses in one year Read More »
Authorities and WHO are investigating a deadly disease outbreak in southwest Congo that killed 143 in November.
Congo health officials investigate deadly disease killing 143 Read More »
The Democratic Republic of Congo’s efforts to combat mpox have been hindered by delays in the delivery of Japanese-donated vaccines, primarily due to legal complexities.
Legal issues stall mpox vaccine for DR Congo’s children Read More »
The global health community is working together to combat the mpox outbreak in Africa, with the WHO allocating 899,000 vaccine doses to nine affected countries.
Africa’s mpox-hit nations receive 899K vaccine doses Read More »
The World Health Organization (WHO) has reported a concerning resurgence of polio in Africa, with 134 new cases detected in seven countries.
WHO reports surge in polio Cases in Africa Read More »
Gilead has announced licensing deals to expand access to its HIV prevention drug, lenacapavir, in lower-income countries.
Gilead’s HIV prevention drug gets a boost from licensing deals Read More »
